Patent details

EP3062809 Title: A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION

Basic Information

Publication number:
EP3062809
PCT Application Number:
IL2014050939
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148022114
PCT Publication Number:
WO2015063768
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION
French Title of Invention:
UN INHIBITEUR PEPTIDIQUE DE CXCR4 POUR LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË AVEC MUTATION DE LA FLT3
German Title of Invention:
EIN CXCR4 PEPTIDE INHIBITOR ZUR BEHANDLUNG VON AKUTER MYELOISCHER LEUKÄMIE MIT EINER FLT3-MUTATION
SPC Number:

Dates

Filing date:
30/10/2014
Grant date:
08/07/2020
EP Publication Date:
07/09/2016
PCT Publication Date:
07/05/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/07/2020
EP B1 Publication Date:
08/07/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/10/2020
Expiration date:
30/10/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/07/2020
 
 

Name:
BioLineRx Ltd.
Address:
2 HaMaayan Street, 7177871 Modiin, Israel (IL)

Name:
Biokine Therapeutics Ltd.
Address:
Building 13a Einstein Street, Science Park Kiryat Weizmann, 7403617 Nes Ziona, Israel (IL)

Inventor

1

Name:
ABRAHAM, Michal
Address:
Israel (IL)

2

Name:
PELED, Amnon
Address:
Israel (IL)

Priority

1

Priority Number:
201361897921 P
Priority Date:
31/10/2013
Priority Country:
United States (US)

2

Priority Number:
201461945302 P
Priority Date:
27/02/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/5377; A61K 31/7068; A61K 38/10; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
202028
Publication date:
08/07/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages